148 related articles for article (PubMed ID: 16227278)
1. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?
Wick WD; Yang OO; Corey L; Self SG
J Virol; 2005 Nov; 79(21):13579-86. PubMed ID: 16227278
[TBL] [Abstract][Full Text] [Related]
2. What do mathematical models tell us about killing rates during HIV-1 infection?
Gadhamsetty S; Beltman JB; de Boer RJ
Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
[TBL] [Abstract][Full Text] [Related]
3. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
5. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus.
Rouzine IM; Sergeev RA; Glushtsov AI
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):666-71. PubMed ID: 16407101
[TBL] [Abstract][Full Text] [Related]
6. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
Joseph A; Zheng JH; Follenzi A; Dilorenzo T; Sango K; Hyman J; Chen K; Piechocka-Trocha A; Brander C; Hooijberg E; Vignali DA; Walker BD; Goldstein H
J Virol; 2008 Mar; 82(6):3078-89. PubMed ID: 18184707
[TBL] [Abstract][Full Text] [Related]
8. A condition for successful escape of a mutant after primary HIV infection.
Monteiro LH; Gonçalves CH; Piqueira JR
J Theor Biol; 2000 Apr; 203(4):399-406. PubMed ID: 10736216
[TBL] [Abstract][Full Text] [Related]
9. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
10. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
Rivière Y
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
Ogg GS; Jin X; Bonhoeffer S; Dunbar PR; Nowak MA; Monard S; Segal JP; Cao Y; Rowland-Jones SL; Cerundolo V; Hurley A; Markowitz M; Ho DD; Nixon DF; McMichael AJ
Science; 1998 Mar; 279(5359):2103-6. PubMed ID: 9516110
[TBL] [Abstract][Full Text] [Related]
13. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo.
Asquith B; Edwards CT; Lipsitch M; McLean AR
PLoS Biol; 2006 Apr; 4(4):e90. PubMed ID: 16515366
[TBL] [Abstract][Full Text] [Related]
14. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
[TBL] [Abstract][Full Text] [Related]
15. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
16. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
[TBL] [Abstract][Full Text] [Related]
17. Modeling plasma virus concentration during primary HIV infection.
Stafford MA; Corey L; Cao Y; Daar ES; Ho DD; Perelson AS
J Theor Biol; 2000 Apr; 203(3):285-301. PubMed ID: 10716909
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA
AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635
[TBL] [Abstract][Full Text] [Related]
19. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
Feeney ME; Tang Y; Roosevelt KA; Leslie AJ; McIntosh K; Karthas N; Walker BD; Goulder PJ
J Virol; 2004 Aug; 78(16):8927-30. PubMed ID: 15280502
[TBL] [Abstract][Full Text] [Related]
20. Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.
Bennett MS; Ng HL; Dagarag M; Ali A; Yang OO
J Virol; 2007 May; 81(10):4973-80. PubMed ID: 17329324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
